SCHEMBL907783

SCHEMBL907783

CC(C(=O)O)c1ccc[nH]c1=O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAPRT Q6XQN6 1/20 0.48
PTGS2 P35354 6/20 0.45
DAO P14920 1/20 0.44
POLB P06746 2/20 0.41
CXCL8 P10145 1/20 0.40
MMP1 P03956 1/20 0.40
MMP2 P08253 1/20 0.40
MMP9 P14780 1/20 0.40
MMP8 P22894 1/20 0.40
MMP12 P39900 1/20 0.40
MMP13 P45452 1/20 0.40
MMP14 P50281 1/20 0.40
MMP16 P51512 1/20 0.40
AURKA O14965 1/20 0.39
AURKB Q96GD4 1/20 0.39
INCENP Q9NQS7 1/20 0.39
PTGS1 P23219 2/20 0.39
KDM4E B2RXH2 2/20 0.37
GAA P10253 2/20 0.37
BLM P54132 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4479803 1.00 NAPRT (0.48) NAPRTPTGS2DAOPOLBCXCL8
SCHEMBL30134219 0.79 DAO (0.48) NAPRTDAOPOLBMMP1MMP2
SCHEMBL830514 0.78 DAO (0.46) NAPRTDAOAURKAAURKBINCENP
SCHEMBL2204495 0.75 PTGS2 (0.56) PTGS2POLBCXCL8MMP1MMP2
SCHEMBL2789316 0.75 PTGS2 (0.42) NAPRTPTGS2POLBCXCL8PTGS1
SCHEMBL19403792 0.75 DAO (0.43) NAPRTDAOPOLBAURKAAURKB
SCHEMBL24108453 0.74 DAO (0.52) NAPRTDAOPOLBAURKAAURKB
SCHEMBL11592656 0.74 NAPRT (0.44) NAPRTDAOPOLBAURKAAURKB
SCHEMBL23479354 0.72 DAO (0.41) NAPRTDAOPOLBAURKAAURKB
SCHEMBL14024571 0.72 TSHR (0.47) NAPRTDAOPOLBAURKAAURKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2970200-A1 PYRIDINE CDK9 KINASE INHIBITORS Abbvie Inc. (US) 2016-01-20 EP disclosed
WO-2014160017-A1 PYRIDINE CDK9 KINASE INHIBITORS ABBVIE INC. (US) 2014-10-02 WO disclosed
EP-2276756-A1 HYDROXYMETHYL PYRROLIDINES AS BETA 3 ADRENERGIC RECEPTOR AGONISTS Merck Sharp & Dohme Corp. (US) 2011-01-26 EP disclosed
EP-2274296-A1 HYDROXYMETHYL PYRROLIDINES AS BETA 3 ADRENERGIC RECEPTOR AGONISTS Merck Sharp & Dohme Corp. (US) 2011-01-19 EP disclosed
WO-2009124166-A1 HYDROXYMETHYL PYRROLIDINES AS BETA 3 ADRENERGIC RECEPTOR AGONISTS MERCK & CO., INC. (US) 2009-10-08 WO disclosed
WO-2009123870-A1 HYDROXYMETHYL PYRROLIDINES AS BETA 3 ADRENERGIC RECEPTOR AGONISTS MERCK & CO., INC. (US) 2009-10-08 WO disclosed
WO-2009124167-A1 HYDROXYMETHYL PYRROLIDINES AS BETA 3 ADRENERGIC RECEPTOR AGONISTS MERCK & CO., INC. (US) 2009-10-08 WO disclosed
US-4159202-A PHOTOCOPYING HOECHST AKTIENGESELLSCHAFT (DE) 1979-06-26 US disclosed